Browse Data and Analysis
Filter
Search Data and Analysis
- 25 results found
- (-) South Korea
- (-) Ukraine
- (-) New Technologies
- Clear all
In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.
The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with European Union regulations.
Ukraine established a simplified procedure for temporary registration of genetically engineered cotton varieties only.
Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.
The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with the European Union’s regulations. Currently no genetically engineered (GE) events are officially...
The biotechnology regulatory system in Ukraine is still not fully developed, but the country is gradually adjusting its domestic policies to align with the European Union’s regulations. Agricultural biotechnology is a disputed item in Ukraine. Currently, no GE events are officially approved for agricultural and food production.
Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.
The biotechnology regulatory system in Ukraine is still not fully developed, but the country has committed to shape its policy in line with European Union’s regulations.
In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.
This report provides minimal updates compared to the previous year’s report.
The biotechnology regulatory system in Ukraine is still not fully developed, but the country has committed to shape its policy in line with European Union standards.
After 10 years under the Living Modified Organism (LMO) Act, Korea plans to improve and revise the LMO Act to address stakeholders’ concerns.